HGF, Human (Rilotumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-HGF, Human (Rilotumumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHGF, Human (Rilotumumab biosimilar)
CloneRilotumumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human HGF Recombinant Antibody (Rilotumumab). Rilotumumab (previously AMG102) is a human monoclonal antibody designed for the treatment of solid tumors. Rilotumumab was in development by Amgen, Inc. until in November 2014, when Amgen announced it had halted all clinical trials of the compound in advanced gastric cancer (including two Phase III studies) after one of the trials found an increase in the number of deaths in those who were taking rilotumumab and chemotherapy when compared to those who were only administered chemotherapy.
Immunogenn/a
Other NamesAnti-HGF Recombinant Antibody, Research Grade Rilotumumab, Anti-Human HGF Recombinant Antibody(Rilotumumab), , Antibody Drug Analogues, Monoclonal Antibody, YR1200, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 872514-65-3
Catalog #YR1200
Priceplease inquire
Order / More InfoHGF, Human (Rilotumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.